8 Blood Transfusion Safety
Learn how to select blood components, administer them safely, recognize transfusion reactions, and respond promptly when a reaction is suspected.
Selecting blood components
Choose a component to address the patient’s clinical problem rather than using blood products simply as volume replacement. The prescriber determines the indication and product; nurses verify the order, administer the component safely, monitor the patient, and report changes. Reassess the patient’s response and need for additional components.
: Improve oxygen-carrying capacity in clinically significant anemia or blood loss.
: Treat or prevent bleeding related to low platelet numbers or impaired platelet function.
: Replace multiple clotting factors in selected patients with bleeding or risk of bleeding and coagulopathy, when a more specific treatment is not appropriate or available.
Cryoprecipitate: Provide fibrinogen in acquired fibrinogen deficiency, especially in critical bleeding or selected procedures.
Preparing and administering a transfusion
Requirements for checks and observations can vary, so follow facility transfusion policy and emergency procedures.
Before transfusion
Verify the prescribed component, amount, timing, infusion instructions, and any special product requirements. Check that informed consent and the indication are documented according to facility policy. Review transfusion history, known antibodies, previous reactions, and relevant risks such as heart or kidney disease and fluid overload.
Assess the patient and record baseline vital signs as required by local policy. Confirm appropriate, patent IV access and explain how to report symptoms promptly.
Immediately before starting, complete the final identity and product check at the bedside. Ask the patient to state identifying details when possible, then compare them with the wristband, transfusion documentation, and component label. Match required identifiers and component details exactly, including compatibility information, donation or unit number, expiry, and special requirements. Use the trained checker or approved electronic process required by local policy. If information does not match, do not start the component; stop and contact the transfusion service.
Inspect the component for leaks, damage, unusual discoloration, clots, or cloudiness. Do not administer a suspect unit; contact the transfusion service.
During transfusion
Use the appropriate blood administration set with filter and follow facility instructions for IV fluid compatibility. 0.9% sodium chloride is commonly used with blood components. Do not add medications to the blood bag or administer them through the same line unless specifically permitted by policy.
Start and complete the component within the time limits and at the rate required by product instructions and local policy. Observe the patient especially closely at the beginning, remain with them during the initial observation period specified by policy, and record observations at required intervals and at completion. Ask the patient to report chills, itching, rash, pain, shortness of breath, or suddenly feeling unwell.
Consider the risk of transfusion-associated circulatory overload (), particularly in patients with cardiac or renal disease, severe anemia, extremes of age, or a positive fluid balance. Follow the prescribed rate and monitoring plan. Do not independently change the rate or give preventive medication without an order or protocol.
Recognizing transfusion reactions
A reaction can begin during transfusion or after it has finished. Possible warning signs include fever, chills or rigors, itching or hives, flushing, anxiety, pain, nausea, breathing difficulty, low oxygen saturation, altered blood pressure, tachycardia, or collapse. For a patient who cannot report symptoms, new changes in vital signs, breathing, behavior, or urine output may be important. Treat a suspected reaction as urgent; do not assume symptoms are harmless or due to the patient’s underlying illness.
Acute hemolytic reaction: May involve fever, rigors, back or flank pain, hypotension, dark urine, or shock; it is often associated with incompatible blood.
Febrile reaction: Fever or chills occur during or soon after transfusion. More serious causes, including hemolysis or bacterial contamination, must be considered.
Allergic or anaphylactic reaction: May cause itching or hives; severe reactions can include airway swelling, wheezing, breathing difficulty, or hypotension.
Septic reaction: May cause fever, rigors, hypotension, or unexplained tachycardia. Bacterial contamination is a particular concern with platelet components.
: Can cause acute breathing difficulty and pulmonary edema related to circulatory overload; risk is higher in patients vulnerable to excess volume.
: Can cause acute hypoxemia and respiratory distress associated with lung injury.
: Symptoms or evidence of hemolysis develop after transfusion rather than immediately. Report new jaundice, dark urine, fever, or an unexpected decline in hemoglobin.
and can both cause acute hypoxemia and pulmonary edema. Bedside staff should report the change promptly rather than trying to make the diagnosis alone.
Responding to a suspected reaction
Act promptly if a reaction is suspected:
Stop the transfusion immediately. Do not restart unless a qualified clinician has assessed the patient and the transfusion service or local protocol supports restarting in the specific situation.
Assess airway, breathing, and circulation. Check vital signs and oxygen saturation. Call for urgent medical help or activate the rapid-response or emergency process for severe symptoms.
Maintain IV access. Follow local procedure; if IV fluid is needed, use a new line or tubing as directed. Do not flush blood remaining in the existing administration set into the patient.
Recheck identification and the component. Compare the patient, wristband, documentation, and unit; inspect the component and tubing for abnormalities.
Notify the prescriber and transfusion service promptly. Follow instructions for returning the component and administration set and collecting blood or urine specimens. Do not discard implicated materials unless directed by policy.
Document and report. Record symptoms, timing, observations, interventions, notifications, and the patient’s response. Complete required transfusion-reaction and safety reports.
Suspected anaphylaxis, sepsis, acute hemolysis, , or may require urgent treatment and investigations directed by the clinical team. Nursing priorities are to stop exposure, support the patient, escalate quickly, and preserve materials for investigation.
For example, if a patient develops chills and new back pain shortly after an RBC transfusion begins, stop the transfusion; assess and monitor airway, breathing, circulation, and vital signs; maintain IV access according to policy; verify patient and unit identity; and urgently notify the clinical team and transfusion service. Do not restart the unit while the reaction is being evaluated.